search
subscribe by email
Twitter
- 
		
Recent Posts
- Twenty Years In Early Stage Biotech VC (Part 3): Business
 - Twenty Years In Early Stage Biotech VC (Part 2): People
 - Twenty Years In Early Stage Biotech VC (Part 1): Science
 - Speed Wins: The Focused-Team Formula for Platform Biotechs
 - A Delicate Balance: Building NewCos with Jacks of All Trades and Utility Players
 
 current comments
topics
- #RunningAtlas (1)
 - Adaptive Sports (1)
 - Atlas Venture (36)
 - Bioentrepreneurship (40)
 - Biotech financing (106)
 - Biotech investment themes (50)
 - Biotech startup advice (69)
 - Boards and governance (16)
 - Boston Cluster (13)
 - Business Development (45)
 - Capital efficiency (27)
 - Capital markets (54)
 - Corporate Culture (57)
 - Diagnostics (2)
 - Drug discovery (29)
 - Exits IPOs M&As (127)
 - External R&D (15)
 - FDA (3)
 - From The Trenches (273)
 - Fundraising (16)
 - General Venture Capital (47)
 - Governance (5)
 - Leadership (39)
 - Marketing (1)
 - New business models (35)
 - Patients (11)
 - Personal (2)
 - Personalized Medicine (4)
 - Pharma industry (75)
 - Portfolio news (66)
 - Pricing and Policy (5)
 - R&D Productivity (27)
 - Rare Diseases (13)
 - Science & Medicine (59)
 - Strategy (7)
 - Talent (55)
 - The Human Element (10)
 - Translational research (42)
 - Uncategorized (24)
 - VC-backed Biotech Returns (67)
 
monthly archive
- October 2025 (3)
 - September 2025 (1)
 - August 2025 (3)
 - July 2025 (3)
 - June 2025 (2)
 - May 2025 (3)
 - April 2025 (3)
 - March 2025 (2)
 - February 2025 (3)
 - January 2025 (1)
 - December 2024 (1)
 - November 2024 (1)
 - October 2024 (2)
 - September 2024 (2)
 - August 2024 (2)
 - July 2024 (3)
 - June 2024 (2)
 - May 2024 (4)
 - April 2024 (4)
 - March 2024 (3)
 - February 2024 (2)
 - January 2024 (4)
 - November 2023 (3)
 - October 2023 (2)
 - September 2023 (1)
 - August 2023 (1)
 - July 2023 (2)
 - June 2023 (1)
 - May 2023 (1)
 - April 2023 (2)
 - March 2023 (3)
 - February 2023 (3)
 - January 2023 (1)
 - December 2022 (2)
 - November 2022 (3)
 - October 2022 (3)
 - September 2022 (1)
 - August 2022 (1)
 - July 2022 (2)
 - June 2022 (4)
 - May 2022 (2)
 - April 2022 (4)
 - March 2022 (7)
 - February 2022 (2)
 - January 2022 (2)
 - November 2021 (5)
 - October 2021 (1)
 - September 2021 (1)
 - August 2021 (2)
 - July 2021 (5)
 - June 2021 (3)
 - May 2021 (3)
 - April 2021 (6)
 - March 2021 (3)
 - January 2021 (2)
 - December 2020 (3)
 - November 2020 (1)
 - October 2020 (6)
 - September 2020 (2)
 - August 2020 (2)
 - July 2020 (3)
 - June 2020 (3)
 - May 2020 (3)
 - April 2020 (6)
 - March 2020 (6)
 - February 2020 (1)
 - January 2020 (1)
 - December 2019 (3)
 - November 2019 (2)
 - October 2019 (2)
 - September 2019 (2)
 - August 2019 (2)
 - July 2019 (1)
 - May 2019 (7)
 - April 2019 (6)
 - March 2019 (1)
 - February 2019 (6)
 - January 2019 (5)
 - December 2018 (1)
 - November 2018 (2)
 - October 2018 (8)
 - September 2018 (4)
 - August 2018 (1)
 - July 2018 (1)
 - June 2018 (4)
 - May 2018 (3)
 - April 2018 (4)
 - March 2018 (4)
 - February 2018 (6)
 - January 2018 (4)
 - December 2017 (3)
 - November 2017 (4)
 - October 2017 (6)
 - September 2017 (4)
 - August 2017 (2)
 - July 2017 (1)
 - June 2017 (5)
 - May 2017 (4)
 - April 2017 (1)
 - March 2017 (5)
 - February 2017 (2)
 - January 2017 (7)
 - December 2016 (3)
 - November 2016 (4)
 - October 2016 (3)
 - September 2016 (6)
 - August 2016 (5)
 - July 2016 (3)
 - June 2016 (6)
 - May 2016 (5)
 - April 2016 (4)
 - March 2016 (7)
 - February 2016 (5)
 - January 2016 (6)
 - December 2015 (6)
 - November 2015 (3)
 - October 2015 (4)
 - September 2015 (5)
 - August 2015 (3)
 - July 2015 (3)
 - June 2015 (4)
 - May 2015 (6)
 - April 2015 (6)
 - March 2015 (7)
 - February 2015 (7)
 - January 2015 (5)
 - December 2014 (4)
 - November 2014 (3)
 - October 2014 (7)
 - September 2014 (5)
 - August 2014 (5)
 - July 2014 (4)
 - June 2014 (6)
 - May 2014 (5)
 - April 2014 (5)
 - March 2014 (6)
 - February 2014 (4)
 - January 2014 (5)
 - December 2013 (3)
 - November 2013 (2)
 - October 2013 (4)
 - September 2013 (3)
 - August 2013 (1)
 - July 2013 (2)
 - June 2013 (2)
 - May 2013 (4)
 - April 2013 (2)
 - March 2013 (4)
 - February 2013 (1)
 - January 2013 (3)
 - December 2012 (3)
 - November 2012 (4)
 - October 2012 (3)
 - September 2012 (4)
 - August 2012 (3)
 - July 2012 (3)
 - June 2012 (4)
 - May 2012 (3)
 - April 2012 (2)
 - March 2012 (3)
 - February 2012 (3)
 - January 2012 (6)
 - December 2011 (4)
 - November 2011 (4)
 - October 2011 (3)
 - September 2011 (4)
 - August 2011 (3)
 - July 2011 (4)
 - June 2011 (4)
 - May 2011 (5)
 - April 2011 (8)
 - March 2011 (10)
 
Tag Archives: Board evolution
Farewell to Zafgen: A Personal Reflection On Board Evolution
June 7, 2018
				Today, Zafgen announced my resignation from their Board of Directors after 12 years of service. It’s a bittersweet moment for me: having been there since the beginning, I’ve watched, and supported, the Zafgen story through all the ups and downs



